Published in Ann Surg on November 01, 2016
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
Resection or Transplant in Early Hepatocellular Carcinoma. Dtsch Arztebl Int (2017) 0.75
Twenty years after: from Milan criteria to a "blended" approach. Transl Gastroenterol Hepatol (2017) 0.75
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution. Transl Gastroenterol Hepatol (2017) 0.75
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer. Ann Surg Oncol (2017) 0.75
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. Cardiology (2010) 2.88
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73
Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. Transpl Int (2013) 2.53
Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging (2009) 2.48
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol (2012) 2.28
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl (2002) 2.18
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int (2011) 2.14
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Liver Transpl (2013) 2.09
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol (2008) 1.98
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology (2004) 1.82
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Diagnosis of acute pulmonary embolism in outpatients: comparison of thin-collimation multi-detector row spiral CT and planar ventilation-perfusion scintigraphy. Radiology (2003) 1.64
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl (2005) 1.52
Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging (2010) 1.51
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging (2010) 1.48
Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. Eur J Gastroenterol Hepatol (2007) 1.42
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Liver segmentation in living liver transplant donors: comparison of semiautomatic and manual methods. Radiology (2004) 1.39
Is portal hypertension a contraindication to hepatic resection? Ann Surg (2009) 1.34
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl (2006) 1.31
The place of liver transplantation in Caroli's disease and syndrome. Transpl Int (2006) 1.23
Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol (2003) 1.15
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. J Hepatol (2012) 1.14
Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg (2005) 1.11
Waiting time and transplantation for hepatocellular cancer: a balance between Tempus Fugit and Carpe Diem. Hepatology (2015) 1.08
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease? Nephrol Dial Transplant (2010) 1.08
Inflammation-based scores and hepatocellular carcinoma: "Faithful friends are hard to find". Liver Transpl (2014) 1.07
α-Fetoprotein and hepatocellular cancer recurrence: a paradigm of the chaos theory. Liver Transpl (2014) 1.04
Congenital intrahepatic bile duct dilatation is a potentially curable disease: long-term results of a multi-institutional study. Ann Surg (2007) 1.03
Endovascular treatment of an aneurysmal aberrant right subclavian artery. J Endovasc Ther (2003) 1.01
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg (2007) 1.01
Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. EJNMMI Res (2012) 1.01
The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg (2007) 0.99
Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. Eur J Gastroenterol Hepatol (2006) 0.98
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg (2006) 0.95
Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology (2003) 0.95
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res (2004) 0.95
Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria. Transpl Int (2012) 0.95
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center. Transplantation (2009) 0.94
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol (2013) 0.94
Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg (2006) 0.93
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant (2010) 0.93
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation. Pharmacogenet Genomics (2007) 0.92
Acute aortic syndromes: Role of multi-detector row CT. Eur J Radiol (2007) 0.91
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system. Liver Transpl (2011) 0.91
Transvascular coil hooking procedure to retrieve an unraveled Guglielmi detachable coil: technical note. Neurosurgery (2002) 0.91
From interventional radiology to laparoscopic liver resection as complementary strategies in the treatment of hepatic abscess caused by ingested foreign bodies. Hepatogastroenterology (2012) 0.91
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl (2008) 0.90
Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Transpl Int (2006) 0.90
Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion. Obes Surg (2012) 0.90
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review. Transpl Int (2010) 0.89
Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children. Pediatr Radiol (2002) 0.88
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation (2013) 0.87
Liver transplantation with left lateral segments in adults: a risk or a possibility? Transplantation (2009) 0.87
Transjugular intrahepatic portosystemic shunts in children with biliary atresia. Cardiovasc Intervent Radiol (2002) 0.87
Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int (2011) 0.87
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med (2009) 0.86
Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides (2012) 0.86
C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med (2014) 0.86
Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis (2011) 0.85
Surgical clipping may lead to better results than coil embolization: results from a series of 101 consecutive unruptured intracranial aneurysms. Neurosurgery (2003) 0.85
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis. Am J Pathol (2013) 0.85
Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve. Transplantation (2004) 0.85
CIRSE vascular closure device registry. Cardiovasc Intervent Radiol (2010) 0.84
Open source software in a practical approach for post processing of radiologic images. Radiol Med (2014) 0.84
Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007. Transpl Int (2009) 0.83
Renal allograft implantation on prosthetic vascular grafts: short- and long-term results. World J Surg (2013) 0.83
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome. Transplantation (2008) 0.83
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants. Radiol Med (2014) 0.83
Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma. Ann Surg (2007) 0.83
Celiac artery occlusive disease: a rare but potentially critical condition in patients undergoing pancreaticoduodenectomy. Hepatogastroenterology (2011) 0.83
Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol (2003) 0.82
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol (2005) 0.82
The many faces of aortic dissections: Beware of unusual presentations. Eur J Radiol (2007) 0.82
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl (2008) 0.82
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol (2010) 0.81
Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance. Acta Gastroenterol Belg (2005) 0.81
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. Dig Liver Dis (2012) 0.81
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. Transpl Int (2012) 0.81
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection. Int J Mol Sci (2013) 0.81
Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int (2005) 0.81
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther Drug Monit (2009) 0.81
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report. Liver Int (2007) 0.81
Nested stromal-epithelial tumor (NSET) of the liver: a case report of an extremely rare tumor. Pathol Res Pract (2009) 0.80
HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res (2011) 0.80